Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
DNA Repair (Amst) ; 72: 86-92, 2018 12.
Article in English | MEDLINE | ID: mdl-30268364

ABSTRACT

The N protein of phage Mu was indicated from studies in Escherichia coli to hold linear Mu chromosomes in a circular conformation by non-covalent association, and thus suggested potentially to bind DNA double-stranded ends. Because of its role in association with linear Mu DNA, we tested whether fluorescent-protein fusions to N might provide a useful tool for labeling DNA damage including double-strand break (DSB) ends in single cells. We compared N-GFP with a biochemically well documented DSB-end binding protein, the Gam protein of phage Mu, also fused to GFP. We find that N-GFP produced in live E. coli forms foci in response to DNA damage induced by radiomimetic drug phleomycin, indicating that it labels damaged DNA. N-GFP also labels specific DSBs created enzymatically by I-SceI double-strand endonuclease, and by X-rays, with the numbers of foci corresponding with the numbers of DSBs generated, indicating DSB labeling. However, whereas N-GFP forms about half as many foci as GamGFP with phleomycin, its labeling of I-SceI- and X-ray-induced DSBs is far less efficient than that of GamGFP. The data imply that N-GFP binds and labels DNA damage including DSBs, but may additionally label phleomycin-induced non-DSB damage, with which DSB-specific GamGFP does not interact. The data indicate that N-GFP labels DNA damage, and may be useful for general, not DSB-specific, DNA-damage detection.


Subject(s)
Bacteriophage mu/genetics , Bacteriophage mu/metabolism , DNA Damage , Fluorescent Dyes/metabolism , Viral Regulatory and Accessory Proteins/metabolism , DNA Breaks, Double-Stranded , Escherichia coli/cytology , Exonucleases/metabolism , Phleomycins/metabolism
2.
J Biotechnol ; 169: 82-6, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24246269

ABSTRACT

Acremonium chrysogenum is the natural producer of the beta-lactam antibiotic cephalosporin C and therefore of significant biotechnological importance. Here we identified and characterized the xylanase-encoding xyl1 gene and demonstrate that its promoter, xyl1(P), is suitable for conditional expression of heterologous genes in A. chrysogenum. This was shown by xylose and xylan-inducible xyl1(P)-driven expression of genes encoding green fluorescence protein and phleomycin resistance. Moreover, we demonstrate the potential of the xyl1(P) promoter for selection marker recycling. Taken together, these finding will help to overcome the limitation in genetic tools in this important filamentous fungus.


Subject(s)
Acremonium/genetics , Gene Expression Regulation/drug effects , Promoter Regions, Genetic , Xylans/pharmacology , Xylose/pharmacology , Xylosidases/genetics , Acremonium/drug effects , Acremonium/metabolism , Gene Expression Regulation/genetics , Phleomycins/metabolism
3.
Microb Cell Fact ; 12: 96, 2013 Oct 25.
Article in English | MEDLINE | ID: mdl-24161108

ABSTRACT

BACKGROUND: Manipulations in Saccharomyces cerevisiae classically depend on use of auxotrophy selection markers. There are several disadvantages to this in a microbial cell factory setting: (1) auxotrophies must first be engineered in prototrophic strains, and many industrial strains are polyploid/aneuploid prototrophs (2) available strain auxotrophies must be paired with available repair plasmids (3) remaining auxotrophies must be repaired prior to development of industrial bioprocesses. Use of dominant antibiotic resistance markers can circumvent these problems. However, there are relatively few yeast antibiotic resistance marker vectors available; furthermore, available vectors contain only one expression cassette, and it is often desirable to introduce more than one gene at a time. RESULTS: To overcome these problems, eight new shuttle vectors have been developed. The plasmids are maintained in yeast under a 2 µm ori and in E. coli by a pUC ori. They contain two yeast expression cassettes driven by either (1) the constitutive TEF1 and PGK1 promoters, or (2) the constitutive TEF1 promoter and the inducible GAL10 or HXT7 promoters. Expression strength of these promoters over a typical production time frame in glucose/galactose medium was examined, and identified the TEF1 and HXT7 promoters as preferred promoters over long term fermentations. Selection is provided by either aphA1 (conferring resistance to G418 in yeast and kanamycin/neomycin in E. coli) or ble (conferring resistance to phleomycin in both yeast and E. coli). Selection conditions for these plasmids/antibiotics in defined media were examined, and selection considerations are reviewed. In particular, medium pH has a strong effect on both G418 and phleomycin selection. CONCLUSIONS: These vectors allow manipulations in prototrophic yeast strains with expression of two gene cassettes per plasmid, and will be particularly useful for metabolic engineering applications. The vector set expands the (currently limited) selection of antibiotic marker plasmids available for use in yeast, and in addition makes available dual gene expression cassettes on individual plasmids using antibiotic selection. The resistance gene cassettes are flanked by loxP recognition sites to allow CreA-mediated marker removal and recycling, providing the potential for genomic integration of multiple genes. Guidelines for selection using G418 and phleomycin are provided.


Subject(s)
Escherichia coli/genetics , Phleomycins/metabolism , Plasmids/genetics , Saccharomyces cerevisiae/metabolism , Gene Expression , Promoter Regions, Genetic , Saccharomyces cerevisiae/genetics
4.
FEMS Yeast Res ; 13(3): 354-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23374647

ABSTRACT

We designed an efficient transformation system for Candida guilliermondii wild-type strains. We demonstrated that the Staphylococcus aureus MRSA 252 ble coding sequence placed under the control of the yeast phosphoglycerate kinase gene transcription-regulating regions confers phleomycin resistance to transformed C. guilliermondii cells. To illustrate the potential of this drug-resistant cassette, we carried out the disruption of the C. guilliermondii ADE2 gene. This new dominant selectable marker represents a powerful tool to study the function of various genes in this yeast of clinical and biotechnological interest.


Subject(s)
Antifungal Agents/metabolism , Bacterial Proteins/biosynthesis , Candida/genetics , Drug Resistance, Microbial , Gene Transfer Techniques , Phleomycins/metabolism , Transformation, Genetic , Bacterial Proteins/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Fungal/chemistry , DNA, Fungal/genetics , Gene Expression , Genetic Vectors , Methicillin-Resistant Staphylococcus aureus/genetics , Molecular Sequence Data , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Selection, Genetic , Sequence Analysis, DNA
5.
Nucleic Acids Res ; 30(22): 4881-91, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12433991

ABSTRACT

The bleomycins (BLMs) are natural products that in the presence of iron and oxygen bind to and cause single-strand and double-strand cleavage of DNA. The mode(s) of binding of the FeBLMs that leads to sequence-specific cleavage at pyrimidines 3' to guanines and chemical-specific cleavage at the C-4' H of the deoxyribose of the pyrimidine has remained controversial. 2D NMR studies using the hydroperoxide of CoBLM (HOO-CoBLM) have demonstrated that its bithiazole tail binds by partial intercalation to duplex DNA. Studies with ZnBLM demonstrate that the bithiazole tail binds in the minor groove. Phleomycins (PLMs) are BLM analogs in which the penultimate thiazolium ring of the bithiazole tail is reduced. The disruption of planarity of this ring and the similarities between FePLM- and FeBLM-mediated DNA cleavage have led Hecht and co-workers to conclude that a partial intercalative mode of binding is not feasible. The interaction of HOO-CoPLM with d(CCAGGCCTGG)2 has therefore been investigated. Binding studies indicate a single site with a K(d) of 16 micro M, 100-fold greater than HOO-CoBLM for the same site. 2D NMR methods and molecular modeling using NMR-derived restraints have led to a structural model of HOO-CoPLM complexed to d(CCAGGCCTGG)2. The model reveals a partial intercalative mode of binding and the basis for sequence specificity of binding and chemical specificity of cleavage. The importance of the bithiazoles and the partial intercalative mode of binding in the double-strand cleavage of DNA is discussed.


Subject(s)
Models, Molecular , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/metabolism , Phleomycins/chemistry , Phleomycins/metabolism , Base Sequence , Binding Sites , Copper/chemistry , Copper/metabolism , Iron/chemistry , Kinetics , Macromolecular Substances , Nuclear Magnetic Resonance, Biomolecular , Nucleic Acid Conformation , Peroxides/chemistry , Peroxides/metabolism , Protons
6.
Appl Environ Microbiol ; 64(9): 3202-8, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9726860

ABSTRACT

Cell extracts of Trichoderma reesei exhibited dibasic endopeptidase activity toward the carboxylic side of KR, RR, and PR sequences. This activity was stimulated by the presence of Ca2+ ions and localized in vesicles of low bouyant density; it therefore exhibited some similarity to yeast Kex2. Analytical chromatofocusing revealed a single peak of activity. The dibasic endopeptidase activity was strongly and irreversibly inhibited in vitro as well as in vivo by 1 mM p-amidinophenylmethylsulfonyl fluoride (pAPMSF) but not by PMSF at concentrations up to 5 mM. We therefore used pAPMSF to study the role of the dibasic endopeptidase in the secretion of protein by T. reesei. Secretion of xylanase I (proprotein processing sequence -R-R- downward arrow-R- downward arrow-A-) and xylanase II (-K-R- downward arrow-Q-) was strongly inhibited by 1 mM pAPMSF, and a larger, unprocessed enzyme form was detected intracellularly under these conditions. Secretion of cellobiohydrolase II (CBH II; -E-R- downward arrow-Q-) was only slightly inhibited by pAPMSF, and no accumulation of unprocessed precursors was detected. In contrast, secretion of CBH I (-R-A- downward arrow-Q-) was stimulated by pAPMSF addition, and a simultaneous decrease in the concentration of intracellular CBH I was detected. Similar experiments were also carried out with a single heterologous protein, ShBLE, the phleomycin-binding protein from Streptoalloteichus hindustanus, fused to a series of model proprotein-processing sequences downstream of the expression signals of the Aspergillus nidulans gpdA promoter. Consistent with the results obtained with homologous proteins, pAPMSF inhibited the secretion of ShBLE with fusions containing dibasic (RK and KR) target sequences, but it even stimulated secretion in fusions to LR, NHA, and EHA target sequences. Addition of 5 mM PMSF, a nonspecific inhibitor of serine protease, nonspecifically inhibited the secretion of heterologous proteins from fusions bearing the NHA and LR targets. These data point to the existence of different endoproteolytic proprotein processing enzymes in T. reesei and demonstrate that dibasic processing is obligatory for the secretion of the proproteins containing this target.


Subject(s)
Endopeptidases/metabolism , Fungal Proteins/metabolism , Protein Processing, Post-Translational , Trichoderma/metabolism , Amino Acid Sequence , DNA, Fungal/isolation & purification , Genotype , Molecular Sequence Data , Peptide Hydrolases/metabolism , Phenylmethylsulfonyl Fluoride/analogs & derivatives , Phenylmethylsulfonyl Fluoride/pharmacology , Phleomycins/metabolism , Plasmids/genetics , Protease Inhibitors/pharmacology , Subcellular Fractions/enzymology , Tosyl Compounds/pharmacology , Trichoderma/enzymology , Trichoderma/genetics , Trichoderma/growth & development
7.
Genetics ; 135(3): 731-40, 1993 Nov.
Article in English | MEDLINE | ID: mdl-7507454

ABSTRACT

To study peroxisome biogenesis, we developed a procedure to select for Saccharomyces cerevisiae mutants defective in peroxisomal protein import or peroxisome assembly. For this purpose, a chimeric gene was constructed encoding the bleomycin resistance protein linked to the peroxisomal protein luciferase. In wild-type cells this chimeric protein is imported into the peroxisome, which prevents the neutralizing interaction of the chimeric protein with its toxic phleomycin ligand. Peroxisomal import and peroxisome assembly mutants are unable to import this chimeric protein into their peroxisomes. This enables the bleomycin moiety of the chimeric protein to bind phleomycin, thereby preventing its toxicity. The selection is very efficient: upon mutagenesis, 84 (10%) of 800 phleomycin resistant colonies tested were unable to grow on oleic acid. This rate could be increased to 25% using more stringent selection conditions. The selection procedure is very specific; all oleic acid non utilizing (onu) mutants tested were disturbed in peroxisomal import and/or peroxisome assembly. The pas (peroxisome assembly) mutants that have been used for complementation analysis represent 12 complementation groups including three novel ones, designated pas20, pas21 and pas22.


Subject(s)
Microbodies/metabolism , Mutation , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Bleomycin/pharmacology , Drug Resistance, Microbial/genetics , Fungal Proteins/genetics , Fungal Proteins/metabolism , Genes, Fungal , Genetic Complementation Test , Genetic Techniques , Luciferases/genetics , Luciferases/metabolism , Microbodies/drug effects , Phleomycins/metabolism , Phleomycins/pharmacology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/ultrastructure
8.
J Mol Biol ; 207(3): 645-6, 1989 Jun 05.
Article in English | MEDLINE | ID: mdl-2474660

ABSTRACT

Large single crystals of a glycopeptide resistance protein encoded by the SH-ble gene from Streptoalloteichus hindustanus have been grown using vapor diffusion techniques with ammonium sulfate as the precipitant. The diffraction pattern extends to 2.0 A resolution. The crystals belong to space group P4(1)2(1)2 or P4(3)2(1)2 and have unit cell dimensions of a = 48.8 A and c = 112.5 A.


Subject(s)
Actinomycetales/metabolism , Bacterial Proteins , Bleomycin/metabolism , Phleomycins/metabolism , Crystallization , X-Ray Diffraction
9.
Biochem J ; 243(3): 847-51, 1987 May 01.
Article in English | MEDLINE | ID: mdl-2444208

ABSTRACT

The binding of phleomycin and bleomycin to DNA has been investigated by studying their effects on cleavage by DNAase I and micrococcal nuclease. In the presence of cobalt, cleavage of DNA by the antibiotics is suppressed, yet they still provide protection from nuclease attack in regions surrounding the drug cleavage sites. We conclude that cleavage by phleomycin occurs at bonds around which the antibiotic is already selectively bound.


Subject(s)
Bleomycin/metabolism , DNA/metabolism , Phleomycins/metabolism , Autoradiography , Base Sequence , Binding Sites , Cobalt , Deoxyribonuclease I , Micrococcal Nuclease
10.
Life Sci ; 32(26): 2915-31, 1983 Jun 27.
Article in English | MEDLINE | ID: mdl-6191168

ABSTRACT

Methods for determining sequence specificities of anticancer drugs, carcinogens, and mutagens which interact with natural DNA's are presented. For drugs which nick or covalently bind to DNA and thus leave a permanent record of their residence position on the helix, the sequences important in drug action can be readily determined. For agents which interact with DNA in an equilibrium fashion, "footprinting" analysis, a technique used to investigate protein-DNA binding, has proved to be useful in studying drug-DNA interactions. The sequence specificities of a number of small ligands which interact with natural DNA's are also presented.


Subject(s)
Anti-Bacterial Agents , DNA/metabolism , Organometallic Compounds , Pharmaceutical Preparations/metabolism , Anti-Bacterial Agents/metabolism , Base Sequence , Bleomycin/metabolism , Cisplatin/metabolism , DNA Restriction Enzymes/metabolism , Dactinomycin/metabolism , Distamycins/metabolism , Doxorubicin/metabolism , Edetic Acid/analogs & derivatives , Edetic Acid/metabolism , Humans , Iron/metabolism , Methods , Micrococcal Nuclease/metabolism , Netropsin/metabolism , Peptides/metabolism , Phenanthrolines/metabolism , Phleomycins/metabolism , Plicamycin/metabolism , Substrate Specificity , Zinostatin/metabolism
11.
Cytobios ; 20(77): 43-70, 1977.
Article in English | MEDLINE | ID: mdl-82502

ABSTRACT

Phleomycin has devastating effects on regeneration of skeletal muscle when applied during an early wave of replication in the pre-myotube (new fibre) period of the reaction. The effect cannot be explained from the contribution of dividing cells to myotubes. Phleomycin's effects on regeneration are much less severe when the challenge coincides with a later wave of pre-myotube proliferation, effects that can be explained from the contribution of such cells to new muscle. An attempt has been made, by means of electron microscopy, to explain how phleomycin distributes early versus late wave cells, using a mercury substitution stain to detect the antibiotic. Cells of the two periods showed conspicuous differences in the staining characteristics of their chromatin. Positive staining reactions outside the nucleus were confined mainly to ribosomes. Exceptions included materials in transit across nuclear and cytoplasmic membranes.


Subject(s)
Anti-Bacterial Agents/metabolism , Muscles/metabolism , Phleomycins/metabolism , Animals , Cell Division , Chromatin/metabolism , Histocytochemistry , Male , Mercury , Mice , Muscles/cytology , Muscles/physiology , Regeneration , Staining and Labeling , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...